Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies.
Saved in:
| Title: | Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. |
|---|---|
| Authors: | Thran M; CureVac SE, 72076, Tübingen, Germany., Pönisch M; CureVac SE, 72076, Tübingen, Germany., Danz H; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA., Horscroft N; CureVac SE, 72076, Tübingen, Germany., Ichtchenko K; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA., Tzipori S; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA., Shoemaker CB; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA. charles.shoemaker@tufts.edu. |
| Source: | Scientific reports [Sci Rep] 2023 Sep 05; Vol. 13 (1), pp. 14632. Date of Electronic Publication: 2023 Sep 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-023-41092-7 |
